Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2661-2666

  Senna, José P M ^a   Roth, Daniela M ^a   Oliveira, Jaim S ^a   Machado, Denise C ^b   Santos, Diógenes S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

DNA vaccine; MRSA; PBP2a

Indexed keywords

BACTERIAL PROTEIN; DNA VACCINE; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBUNIT; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; KIDNEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VACCINATION;

EID: 0038064395     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00738-7     Document Type: Article

References (26)

1. Selvey L.A., Whitby M., Johnson B. Nosocomial methicillin resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin sensitive Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 10:2000;645-648.
2. French G.L., Cheng A.F.et al. Hong Kong strains of methicillin resistant and methicillin sensitive Staphylococcus aureus have similar virulence. J. Hosp. Infect. 15(2):1990;117-125.
3. Chambers H.F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:1997;781-791.
4. Lim D., Strynadka C.J. Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat. Struct. Biol. 9:2002;870-876.
5. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 44:2000;1549-1555.
6. Goffin C., Ghuysen J.M. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Molec. Biol. Rev. 62:1998;1079-1093.
7. Berger-Bächi B. Expression of resistance to methicillin. Trends Microbiol. 2:1994;389-393.
8. Pearson, H. Bacteria defies last-resort antibiotic. Nature 2002:469.
9. Tenover F.C., Lancaster M.V., Hill B.C., Stedward C.D., Stocker S.A., Hancock G.A.et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1998;1020-1027.
10. McKenney D., Pouliot K.L., Wang Y., Murthy V.et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284:1999;1523-1527.
11. Lee J.C., Perez N.E., Hopkins C.A., Pier G.B. Purified capsular polyssaccharide-induced immunity to Staphylococcus aureus infection. J. Infect. Dis. 157:1988;723-731.
12. Geenberg D., Bayer A., Cheung A., Ward J. Protective efficacy of protein-A specific antibody against bacteriemic infection due to Staphylococcus aureus in an infant rat model. Infect. Immun. 57:1989;1113-1120.
13. Ulmer J.B., Donnely J.J., Parker S.E.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
14. Mamo W., Jonsson P., Flock J.I., Lindberg M.et al. Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine. 12:1994;988-992.
15. Ulmer J.B., Donnelly J.J., Liu M.A. DNA vaccines promising: a new approach to inducing protective immunity. ASM News. 62:1996;476-479.
16. Lowrie D.B., Tascon R.E., Silva C.L.et al. Therapy of tuberculosis in mice by DNA vaccination. Nature. 400:1999;269-271.
17. Shiver J.W., Ulmer J.B., Donnely J.J., Liu M.A. Humoral and cellular immunities elicited by DNA vaccines: application to the human immunodeficiency virus and influenza. Adv. Drug Delivery Rev. 21:1996;19-31.
18. Wild J., Gruner B., Metzger K.et al. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine. 16:1998;353-360.
19. Navarre W.W., Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Molec. Biol. Rev. 63:1999;174-229.
20. Vannuffel P., Gigi J., Ezzedine H.et al. Specific detection of methicillin-resistant Staphylococcus aureus species by multiplex-PCR. J. Clin. Microbio. 33:1995;2864-2867.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbour (NY): Cold Spring Harbour Laboratory; 1989.
22. Reed L.J., Muench H.A. Simple method for estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
23. Leonard JM. The arithmetic of decision-making. London: The English University Press; 1971.
24. Krieg A.M. Immune effects and mechanisms of action of CpG motifs. Vaccine. 19:2001;618-622.
25. Deléage G., Combet C., Blanchet C., Geourjon C. ANTHEPROT: an integrated protein sequence analysis software with client/server capabilities. Comput. Biol. Med. 31:2001;259-267.
26. Ohwada A., Sekiya M., Hanaki H. DNA vaccination by mecA sequence evokes na antibacterial immune response against methicillin-resistant Staphylococcus aureus. J. Antimicr. Chemother. 44:1999;767-774.